The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Anticancer Drugs
; 33(7): 663-670, 2022 08 01.
Article
in En
| MEDLINE
| ID: mdl-35703239
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Carcinoma, Intraductal, Noninfiltrating
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Anticancer Drugs
Journal subject:
ANTINEOPLASICOS
Year:
2022
Type:
Article